RBM17 and lung carcinoma: When lung cancer cells are irradiated after knocking down MSI2, there is not enough MSI2 to enter the nucleus after DNA damage occurs, and it cannot interact with RBM17 and ATR to activate ATR, resulting in DNA damage repair not proceeding smoothly.